Chronic treatment with MK-801 increases the quinolinic acid-induced loss of D-1 dopamine receptors in rat striatum
- 1 February 1990
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 176 (3) , 363-366
- https://doi.org/10.1016/0014-2999(90)90031-z
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- The quinolinic acid model of Huntington's disease: Locomotor abnormalitiesExperimental Neurology, 1989
- Loss of D1 and D2 dopamine receptors and muscarinic cholinergic receptors in rat brain following in vitro polytron homogenizationBrain Research Bulletin, 1989
- Effect of MK-801, kynurenate, glycine, dextrorphan and 4-acetylpyridine on striatal toxicity of quinolinateBrain Research, 1989
- NMDA Receptor Losses in Putamen from Patients with Huntington's DiseaseScience, 1988
- Supersensitivity of d-amphetamine-induced hyperthermia in rats following continuous treatment with neurolepticsEuropean Journal of Pharmacology, 1987
- D-1 dopamine receptor changes after striatal quinolinic acid lesionEuropean Journal of Pharmacology, 1987
- Replication of the neurochemical characteristics of Huntington's disease by quinolinic acidNature, 1986
- II. Excitotoxic models for neurodegenerative disordersLife Sciences, 1984
- Quinolinic Acid: An Endogenous Metabolite That Produces Axon-Sparing Lesions in Rat BrainScience, 1983